Teshima T, Chatani M, Hata K, Inoue T, Miyahara Y, Sato T, Shibata H, Kusakabe H, Tateishi T, Suzuki T
Gan No Rinsho. 1985 Apr;31(4):363-9.
Thirty-seven previously untreated cases of primary non-Hodgkin's lymphoma in the head and neck were treated at our department from September 1977 through January 1983. The survival rate at three years by stage was 84% in stage I, 44% in stage II and 0% in stage III and IV. Stage, T- and B-cell markers, initial primary site, the level of lymph node involvement (UICC, 1978) and number were important prognostic factors. Chemotherapy in the pre- or post-radiation period was essential, especially in stage II. It was proved that adequacy of radiation portals with special reference to anatomical considerations was necessary.
1977年9月至1983年1月,我科收治了37例初治的头颈部原发性非霍奇金淋巴瘤患者。按分期计算,I期患者三年生存率为84%,II期为44%,III期和IV期为0%。分期、T细胞和B细胞标志物、初始原发部位、淋巴结受累水平(国际抗癌联盟,1978年)及数量是重要的预后因素。放疗前或放疗后进行化疗至关重要,尤其是II期患者。结果证明,特别考虑解剖因素确定放疗野的范围很有必要。